Diabetes Update This CME/CNE educational session will provide attendees with the knowledge and skills to be familiar with revised Type 2 Diabetes Treatment guidelines incorporating SGLT-2 inhibitors DATE:
Tuesday 17th November 2020: 6.15pm for 6.30pm start - 8.00pm
VENUE:
Conference Centre, Tauranga Hospital (ground floor behind Library)
829 Cameron Road, Tauranga FACILITATORS:
Dr King Wei Yong, Endocrinologist and General Physician and Dr Richard Germann, Nephrologist and General Physician At the end of this session attendees will:
1.
Have an awareness of the clinical evidences of SGLT-2 inhibitors in cardiovascular risk reduction in the treatment of Type 2 Diabetes patients
2.
Be familiar with the revised Type 2 diabetes treatment guidelines incorporating SGLT-2 inhibitors
3.
Understand how to prescribe SGLT-2 inhibitors, their common side effects and how to prevent their potential complications
4.
Recognise the strong evidence for use of SGLT-2 inhibitors in the prevention of progression of diabetic CKD.
5.
Understand the likely special authority criteria for SGLT-2 inhibitors from 1/12/2020 If you prefer to join via webinar, please register on:
https://us02web.zoom.us/webinar/register/WN_7mSoqgy9SS6DqTxCihY5xg Snacks and certificates of attendance will be available on the evening for those attending in person Please RSVP to Jenny Falconer, email: jennyf@wboppho.org.nz
Name
Email Address
Workplace
Contact number
The Royal New Zealand College of General Practitioner RNZCGP Endorsed CPD Activity